Class information for:
Level 1: NUT MIDLINE CARCINOMA//BROMODOMAIN//BRD4

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16900 565 45.3 91%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
181 21089 CHROMATIN//EZH2//NUCLEOSOME

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NUT MIDLINE CARCINOMA Author keyword 69 93% 5% 26
2 BROMODOMAIN Author keyword 53 52% 13% 72
3 BRD4 Author keyword 37 59% 7% 41
4 BRD4 NUT Author keyword 18 89% 1% 8
5 BRD2 Author keyword 15 67% 2% 14
6 JQ1 Author keyword 13 58% 3% 15
7 BET FAMILY Author keyword 9 83% 1% 5
8 BET INHIBITOR Author keyword 9 83% 1% 5
9 RING3 Author keyword 9 83% 1% 5
10 BROMODOMAINS Author keyword 8 56% 2% 10

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 NUT MIDLINE CARCINOMA 69 93% 5% 26 Search NUT+MIDLINE+CARCINOMA Search NUT+MIDLINE+CARCINOMA
2 BROMODOMAIN 53 52% 13% 72 Search BROMODOMAIN Search BROMODOMAIN
3 BRD4 37 59% 7% 41 Search BRD4 Search BRD4
4 BRD4 NUT 18 89% 1% 8 Search BRD4+NUT Search BRD4+NUT
5 BRD2 15 67% 2% 14 Search BRD2 Search BRD2
6 JQ1 13 58% 3% 15 Search JQ1 Search JQ1
7 BET FAMILY 9 83% 1% 5 Search BET+FAMILY Search BET+FAMILY
8 BET INHIBITOR 9 83% 1% 5 Search BET+INHIBITOR Search BET+INHIBITOR
9 RING3 9 83% 1% 5 Search RING3 Search RING3
10 BROMODOMAINS 8 56% 2% 10 Search BROMODOMAINS Search BROMODOMAINS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BET BROMODOMAINS 68 67% 11% 61
2 PROTEIN BRD4 55 87% 5% 27
3 AGGRESSIVE CARCINOMA 38 76% 5% 26
4 EFFECT HOMEOTIC GENE 37 100% 2% 14
5 BROMODOMAIN INHIBITION 33 83% 3% 19
6 FRAGMENT BASED DISCOVERY 31 71% 4% 25
7 ACETYLATED CHROMATIN 31 82% 3% 18
8 BRD4 NUT FUSION ONCOGENE 27 92% 2% 11
9 BRD4 27 50% 7% 39
10 RING3 20 100% 2% 9

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions 2015 4 113 66%
Targeting bromodomains: epigenetic readers of lysine acetylation 2014 55 152 56%
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition 2014 22 75 63%
BET bromodomain inhibitors: a patent review 2014 11 75 80%
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation 2007 163 49 41%
BET domain co-regulators in obesity, inflammation and cancer 2012 92 167 45%
The bromodomain: From epigenome reader to druggable target 2014 9 104 67%
NUT midline carcinoma 2010 35 23 91%
Bromodomains and Their Pharmacological Inhibitors 2014 14 237 46%
Discovery of BET bromodomain inhibitors and their role in target validation 2014 4 79 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EPINOVA DISCOVERY PERFORMANCE UNIT 6 53% 1.4% 8
2 EPINOVA DPU 4 31% 2.1% 12
3 CANC EPIGENET DPU 4 67% 0.7% 4
4 EPINOVA 4 75% 0.5% 3
5 CELLZOME GMBH 3 60% 0.5% 3
6 LIPID METAB DISCOVERY PERFORMANCE UNIT 3 60% 0.5% 3
7 TARGET DISCOVERY 3 12% 3.5% 20
8 MOL GROWTH REGULAT 2 10% 3.7% 21
9 BIOSTATMAILMAN PUBL HLTH 2 67% 0.4% 2
10 GENET DEV OBSTET GYNECOL 2 67% 0.4% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000151114 MYST//MOZ//HISTONE ACETYLTRANSFERASE
2 0.0000103442 P TEFB//CDK9//HEXIM1
3 0.0000093832 SWI SNF//BRG1//ISWI
4 0.0000092086 HISTONE DEMETHYLASE//HISTONE DEMETHYLATION//LSD1
5 0.0000063822 NGX6//BRD7 GENE//NGX6 GENE
6 0.0000056990 HISTONE CHAPERONE//ASF1//CAF 1
7 0.0000053444 BRMS1//BREAST CANCER METASTASIS SUPPRESSOR 1//FDN CANC METASTASIS
8 0.0000048138 HIRANO BODIES//HIRANO BODY//INTRANEURONAL INCLUSIONS
9 0.0000045967 CHIP SEQ//PEAK CALLING//DNASE SEQ
10 0.0000044169 MYC//MAX//C MYC